RDD Europe 2025
Date: May 6-9, 2025
Location: Estoril Congress Center, Portugal
Booth #:
JOIN US!
Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. Schedule a meeting with the Catalent Inhalation team at RDD Europe to discuss how we can partner and help bring your inhaled therapy to market, faster.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Biologics for Nebulization: An Approach to Formulation and Manufacture
Alan Watts, Director Innovation and Partnership, Orally Inhaled Delivery & Jean-Francois Boe, Director Product Development Biologics.
May 7, 2025 | 2:00 PM – 3:00 PM | 3:15 PM – 4:15 PM | 4:30 PM – 5:30 PM
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
